Loose RNA Molecules Rejuvenate Skin, Researchers Discover
Want to smooth out your wrinkles, erase scars and sunspots, and look years younger? Millions of Americans a year turn to lasers and prescription drugs to rejuvenate their skin, but exactly how that rejuvenation works has never been fully explained. Now, Johns Hopkins researchers have discovered that laser treatments and the drug retinoic acid share a common molecular pathway. Moreover, that pathway — which lets skin cells sense loose RNA molecules — is also turned up in mice when they regenerate hair follicles. Results are described in the June 26 issue of Nature Communications.
“Understanding the biology behind how cellular damage can lead to this type of regeneration can harness a new generation of therapeutics,” says Luis Garza, M.D., Ph.D., associate professor of dermatology at the Johns Hopkins University School of Medicine.
The team collected biopsies from 17 patients being treated at The Johns Hopkins Hospital with conventional laser skin rejuvenation to electively erase sunspots and wrinkles. All patients were Caucasian women with an average age of 55, and treatments were performed on their faces and arms. Skin biopsies were collected before the laser treatment and one week after the procedure.
Garza and his colleagues analyzed the expression levels of genes in each sample and discovered that genes involved in sensing dsRNA as well as genes involved in producing the skin’s natural retinoic acid were all expressed at higher levels after the laser treatment. Next, the researchers treated isolated human skin cells with loose dsRNA — mimicking the effect of the laser treatment. The amount of retinoic acid inside the cells increased by more than tenfold. Commercially produced retinoic acid is already used to treat acne, wrinkles and sunspots.
“It’s not an accident that laser rejuvenation and retinoic acid have both been successful treatments for premature aging of the skin from sun damage and other forms of exposure,” says Garza. “They’re actually working in the same molecular pathways and nobody knew that until now.”
To further strengthen and understand the connection, the researchers turned back to mice. They knew that in both mice and humans, a protein called toll-like receptor 3 (TLR3) senses dsRNA. When Garza’s group engineered mice to lack TLR3, the animals could no longer regenerate hair follicles after a wound. But when the researchers gave these mice retinoic acid, they regained the ability to regenerate the follicles. The results point toward a pathway involving TLR3 that senses double-stranded RNA and turns up the synthesis of retinoic acid.
“In retrospect, it makes a lot of sense because retinoic acid is already a mainstay of wrinkle reduction and nobody knew what turned it on,” says Garza. “Now we know that damage leads to dsRNA, which leads to TLR3 activation and retinoic acid synthesis.”
The findings could lead to novel strategies to reduce wrinkles and sunspots by combining retinoic acid and laser treatments in new ways, Garza says. And they could also lead to ways to regenerate hair follicles, as mice do when there’s an increase in dsRNA after a wound.
“After a burn, humans don’t regenerate structures like hair follicles and sweat glands that used to be there,” says Garza. “It’s possible in light of these new findings that double-stranded RNA may be able to improve the appearance of burn scars.”
In addition to Luis Garza, other authors on the Nature Communications paper are Dongwon Kim, Ruosi Chen, Mary Sheu, Noori Kim, Sooah Kim, Nasif Islam, Eric M. Wier, Gaofeng Wang, Ang Li, Angela Park, Wooyang Son, Benjamin Evans, Victoria Yu, Vicky P. Prizmic, Eugene Oh, Zixiao Wang, Nathan K. Archer, Nashay Clemetson, Anna Chien, Ginette A. Okoye, Lloyd S. Miller, Gabriel Ghiaur and Sewon Kang of the Johns Hopkins University School of Medicine; Zhiqi Hu of Nanfang Hospital of Southern Medical University; Jace W. Jones, Maureen A. Kane, Jianshi Yu and Weiliang Huang of University of Maryland; and Amanda M. Nelson of The Pennsylvania State University.
The work and researchers involved were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR064297 and AR068280), the Department of Defense (AFIRM2-ER11 and CDMRPR W81XWH-16-C-0167), Northrup Grumman Electronic Systems, Maryland Stem Cell Research Fund (2017-MSCRFF-3905), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD077260), and the University of Maryland School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014).